Contact

Email

sslwong@unimelb.edu.au

Credentials

Position
Honorary (Senior Fellow)
Department of Medicine

Dr Shirley Wong

Honorary (Senior Fellow)
Department of Medicine
28 Scholarly works
1 Projects

HIGHLIGHTS

  • 2025

    Journal article

    Treatment patterns and outcomes for younger patients with metastatic castration-resistant prostate cancer (mCRPC); An Australian prospective registry study
    DOI: 10.1016/j.clgc.2025.102345
  • 2023

    Journal article

    Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter?
    DOI: 10.1080/14737167.2023.2161048
  • 2022

    Conference Proceedings

    Beyond cabazitaxel: Late line treatments in metastatic castration resistant prostate cancer: A retrospective multicentre analysis
    DOI: 10.1111/ajco.13732
  • 2022

    Journal article

    Predictors of real-world utilisation of docetaxel combined with androgen deprivation therapy in metastatic hormone-sensitive prostate cancer
    DOI: 10.1111/imj.15288
  • 2022

    Journal article

    Real-world first-line systemic therapy patterns in metastatic castration-resistant prostate cancer
    DOI: 10.1002/bco2.129
  • 2022

    Journal article

    Is the search for cerebral palsy ‘cures’ a reasonable and appropriate goal in the 2020s?
    DOI: 10.1111/dmcn.15016
  • 2021

    Research grants (ARC, NHMRC, MRFF)

    Platform to Enhance Prostate Cancer Shared Care Integration (PEPSI)
Shirley Wong

RECENT SCHOLARLY WORKS

  • 2021

    Journal article

    Real-world incidence of symptomatic skeletal events and bone-modifying agent use in castration-resistant prostate cancer – an Australian multi-centre observational study
    DOI: 10.1016/j.ejca.2021.06.005
  • 2021

    Journal article

    Real-world use of first-generation antiandrogens: impact on patient outcomes and subsequent therapies in metastatic castration-resistant prostate cancer
    DOI: 10.1111/bju.15364
  • 2021

    Journal article

    Cancer clinical trial vs real-world outcomes for standard of care first-line treatment in the advanced disease setting
    DOI: 10.1002/ijc.33568
  • 2021

    Journal article

    Treatment outcomes for patients with metastatic castrate-resistant prostate cancer following docetaxel for hormone-sensitive disease
    DOI: 10.1111/ajco.13447